Developed by Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed : October 2009 Most recently updated: September 2011
|
|
- Melvin Murphy
- 6 years ago
- Views:
Transcription
1 Developed by Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed : October 2009 Most recently updated: September 2011
2 To identify the patients who should receive a beta blocker during the perioperative period. To recognize the approved venous thromboembolism (VTE) prophylaxis for surgical patients. To recognize the importance of the VTE prophylaxis being started with 24 hours before to 24 hours after surgery Changes for 2012 will be in italics.
3 This is the only cardiac measure in the current SCIP program. Research has shown that mortality increases when patients who are on beta-blocker therapy prior to admission do not receive a betablocker during the perioperative period
4 For this measure the perioperative period is defined as the day prior to surgery through postoperative day two with day of surgery being day zero. If the patient s length of stay is less that 2 days the administration of the beta blocker the day prior to or day of surgery only are assessed.
5 Nursing role While ordering a medication is a physician responsibility, nurses should remind the physician that the patient was taking a beta blocker prior to admission. Nursing or often anesthesia will administer the medication as ordered. Be sure to document the date and time of the administration.
6 As with the other indicators if the practitioner does not order a beta blocker for patients who are on one prior to admission he/she must document the reason for not ordering this medication. Acceptable reasons include having a ventricular assist device or heart transplantation. The list of approved beta-blockers follows.
7 Approved Beta-Blockers Acebutolol Atenolol Atenolol/chlorthalidone Betapace Betapace AF Betaxolol Bisoprolol Bisoprolol/fumarate Bisoprolol/hydrochlorothiazide Blocadren Brevibloc Bystolic Carteolol Cartrol Carvedilol Coreg Corgard Corzide 40/5 Corzide 80/5 c Acebutolol Coreg
8 Approved Beta-blockers cont. Esmolol Inderal Inderal LA Inderide Inderide LA InnoPran XL Kerledex Kerlone Labetalol Levatol Lopressor Lopressor HCT Metoprolol Metoprolol/hydrochlorothiazide Metoprolol Tartrate/hydrochlorothiazide Nadolol Nadolol/bendroflumethiazide Nebivolol Nebivolol HCL Nebivolol Hydrochloride Normadyne
9 Approved Beta Blockers Normodyne Penbutolol Pindolol Propranolol Propranolol HCL Propranolol Hydrochloride Propranolol/hydrochlorothiazide Sectral Sorine Sotalol Sotalol HCL Tenoretic Tenormin Tenormin I.V. Timolide Timolol Timolol Maleate/hydrochlorothiazide Timolol/hydrochlorothiazide Reference: Specifications Manual for National Hospital Inpatient Quality Measures Discharges 01/01/12 (Q112) through 06/30/12(Q212)
10 The two VTE measures are interlinked. The first is that the appropriate VTE prophylaxis is ordered anytime from hospital arrival to 24 hours after the anesthesia end time. This is a practitioner driven measure. The second is that the ordered VTE prophylaxis is initiated within 24 hours prior to the anesthesia start time to 24 hours after the anesthesia end time. This is a nursing driven measure.
11 There are several groups of patients who are excluded from this indicator. These include: Burn patients Patients whose total surgical time is less than 60 minutes Patients who stay less than two nights. Patients who are on oral anticoagulation therapy prior to admission.
12 There are two types of prophylaxis. 1. Pharmacological which include: Heparin Low molecular weight heparin such as Lovonox Factor Xa inhibitor fondaparinux Arixtra or Xarelto Warfarin (Coumadin)
13 2. Mechanical prophylaxis which include : Graduated Compression Stockings (GCS) Intermittent Pneumatic Compression Devices (IPC) Venous Foot Pump (VFP)
14 Years of research have identified that the type of procedure done drives the choice of VTE prophylaxis. The following slides show the recommendations for each category of surgery. While ordering prophylaxis is the responsibility of the practitioner, the nurses caring for post-op patients should look for some type of order or documentation as to why nothing was ordered.
15 Procedure Recommended prophylaxis Elective Total Knee Replacement Hip Fracture surgery Elective Total hip replacement Any of the following Low molecular weight heparin Factor Xa inhibitor including oral route (Xarelto) Warfarin ICP VFP Low molecular weight inhibitor Low dose unfractionated heparin Factor Xa Inhibitor Warfarin Low molecular weight heparin Factor Xa inhibitor including oral route (Xarelto) Warfarin
16 Elective Total hip replacement with reason documented for not administering pharmacological VTE Intermittent Pneumatic Compression device (ICP) Venous Foot Pump VFP Hip Fracture surgery with reason documented for not administering pharmacological VTE Urologic Surgery Graduated Compression Stockings (GCS) Intermittent Pneumatic Compression device (ICP) Venous Foot Pump VFP Low molecular weight inhibitor Low dose unfractionated heparin Factor Xa Inhibitor IPC GCS Pharmacological combined with IPC or GCS
17 General Surgery General surgery with reason documented for not receiving pharmacological VTE Gynecologic Surgery Intracranial Neurosurgery Low molecular weight inhibitor Low dose unfractionated heparin Factor Xa Inhibitor Pharmacological combined with IPC or GCS GCS IPC Low molecular weight inhibitor Low dose unfractionated heparin Factor Xa Inhibitor IPC Pharmacological combined with IPC or GCS Low molecular weight inhibitor Low dose unfractionated heparin IPC with or without GCS Any combination of the pharmacological and mechanical listed above.
18 As you see in the previous charts the first choice of prophylaxis for VTE prevention is medication with or without any mechanical device use. When the patient has a documented contraindication such as recent GI bleed, the mechanical device prophylaxis can be used alone.
19 Regardless of the treatment ordered it must be initiated in the time frame of 24 hours prior to anesthesia start time to 24 hours after the anesthesia end time. Nursing and Pharmacy need to work together to assure the medications are available, administered and the start time documented within this window.
20 The SCIP core measure set is the most complicated of all. Not only are there the most measures but there are specific time limits designated for six of these indicators. The role of nursing is huge. Not only do you need to know the recommendations but you must be sure that each measure is addressed within the designated timeframe. As with the other CMS core measures each indicator requires an action and concise documentation.
21 Reducing the complications of surgery continues to be one of the National Patient Safety Goals and a goal of the health care reform movement. While there are no new measures added through 06/30/2012 there are surgical measures included in the list under consideration for future use.
22 1. Patients who are taking a beta blocker prior to arrival for surgery and receive general anesthesia should have a dose given during the perioperative period which ends at discharge from PACU. A. True B. False
23 2. The SCIP VTE measures will be met as long as you get that patient out of bed on post-op day 1. A. True B. False
24 3. Heparin or Lovonox can be given up to hour(s) before anesthesia start time and still be considered appropriate treatment according to the SCIP guidelines. A. 4 B. 16 C. 24 D. 48
25 4. The first choice for VTE prophylaxis is pharmacological with or without a mechanical device. A. True B. False
AMI Talking Points. Provide appropriate treatment to Acute MI patients with these core measures:
AMI Provide appropriate treatment to Acute MI patients with these core measures: Aspirin received within 24 hours of arrival or contraindication documented Primary PCI Received Within 90 Minutes of Hospital
More informationIMPORTANT INFORMATION REGARDING YOUR NUCLEAR STRESS TEST
Name: Day One Appointment Day Two Appointment Test Results Appointment Time: Time: Time: IMPORTANT INFORMATION REGARDING YOUR NUCLEAR STRESS TEST A Stress test sometimes also called a treadmill test, helps
More informationALLERGY PACKET PLEASE READ IMMEDIATELY AND BRING COMPLETED PACKET TO YOUR APPOINTMENT.
ALLERGY PACKET PLEASE READ IMMEDIATELY AND BRING COMPLETED PACKET TO YOUR APPOINTMENT. Huntsville Allergy Clinic 927 Franklin Street, Suite 100 Huntsville, AL 35801 256-489-2128 Madison Allergy Clinic
More informationObjectives. Venous Thromboembolism (VTE) Prophylaxis. Case VTE WHY DO IT? Question: Who Is At Risk?
Objectives Venous Thromboembolism (VTE) Prophylaxis Rishi Garg, MD Department of Medicine Identify patients at risk for VTE Options for VTE prophylaxis Current Recommendations (based on The Seventh ACCP
More informationInformation for Vermont Prescribers of Prescription Drugs Long Form Bystolic (nebivolol) Tablets
Information for Vermont Prescribers of Prescription Drugs Long Form Bystolic (nebivolol) Tablets The prices listed below are Average Wholesale Prices ( AWP ) as established and made available to the public
More informationAllergy Testing Information
Allergy Testing Information Allergy skin testing takes approximately 1 to 1 ½ hours. Please eat a light breakfast if you are scheduled for a morning appointment. DO NOT SKIP BREAKFAST. If you are scheduled
More informationENT SURGICAL CONSULTANTS. LTD Glenwood Avenue, Joliet, Illinois * (815) Office (815) Allergy Dept. (815) Fax
ENT SURGICAL CONSULTANTS. LTD. 2201 Glenwood Avenue, Joliet, Illinois 60435 * (815) 725-1191 Office (815) 531-3804 Allergy Dept. (815) 725-1248 Fax Michael G. Gartlan Rajeev H. Mehta Scott DiVenere Sung
More informationBeta-Blocker Step Therapy Program
Beta-Blocker Step Therapy Program Policy Number: 5.01.582 Last Review: 7/2018 Origination: 7/2014 Next Review: 7/2019 LoB: ACA Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage
More informationPrevention of Venous Thromboembolism
Prevention of Venous Thromboembolism Surgical Care Improvement Project Dale W. Bratzler, DO, MPH President and CEO Dale W. Bratzler, DO, MPH Oklahoma Foundation for Medical Quality QIOSC Medical Director
More informationDENOMINATOR: All surgical patients aged 18 years and older undergoing procedures for which VTE prophylaxis is indicated in all patients
Measure #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) National Quality Strategy Domain: Patient Safety 2017 OPTIONS FOR INDIVIDUAL MEASURES:
More informationData Dictionary ; Revised ; ; , Items in bold italics are recent changes/additions
Data Dictionary 05.31.06; Revised 06.12.06; 07.24.06; 12.30.06, 07.07 Items in bold italics are recent changes/additions Demographic information First initial last name Provide only the first initial of
More informationAnticoagulation for prevention of venous thromboembolism
Anticoagulation for prevention of venous thromboembolism Original article by: Michael Tam Note: updated in June 2009 with the eighth edition (from the seventh) evidence-based clinical practice guidelines
More informationTexas Prior Authorization Program Clinical Criteria. Allergen Extracts
Texas Prior Authorization Program Clinical Criteria Drug/Drug Class Clinical Information Included in this Document Oralair (Mixed Grass Pollens Allergen Extract)) Drugs requiring prior authorization: the
More informationCPT only copyright 2014 American Medical Association. All rights reserved. 12/23/2014 Page 66 of 593
Measure #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) National Quality Strategy Domain: Patient Safety 2015 PQRS OPTIONS FOR INDIVIDUAL MEASURES:
More informationQuality Improvement Updates Foley Discontinuation Protocol Surgical Care Improvement Project
Quality Improvement Updates Foley Discontinuation Protocol Surgical Care Improvement Project Barbara J Martin, RN, MBA Quality Consultant, Center for Clinical Improvement Indwelling Urinary Catheters Insertion,
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) National Quality Strategy Domain: Patient Safety 2018 OPTIONS FOR INDIVIDUAL MEASURES:
More informationVenous Thromboembolism. Prevention
Venous Thromboembolism Prevention August 2010 Venous Thromboembloism Prevention 1 1 Expected Practice Assess all patients upon admission to the ICU for risk factors of venous thromboembolism (VTE) and
More informationSlide 1. Slide 2. Slide 3. Outline of This Presentation
Slide 1 Current Approaches to Venous Thromboembolism Prevention in Orthopedic Patients Hujefa Vora, MD Maria Fox, RN June 9, 2017 Slide 2 Slide 3 Outline of This Presentation Pathophysiology of venous
More informationsympathetic nerve impulses endogenous catecholamines beta adrenergic drugs
Beta adrenergic blockers } These drugs will bind and prevent beta-receptors from responding to: sympathetic nerve impulses endogenous catecholamines beta adrenergic drugs the use of beta antagonists is
More informationNOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.
TITLE VENOUS THROMBOEMBOLISM PROPHYLAXIS SCOPE Provincial Acute and Sub-Acute Care Facilities APPROVAL AUTHORITY Alberta Health Services Executive Committee SPONSOR Vice President, Quality and Chief Medical
More informationMisunderstandings of Venous thromboembolism prophylaxis
Misunderstandings of Venous thromboembolism prophylaxis Veerendra Chadachan Senior Consultant Dept of General Medicine (Vascular Medicine and Hypertension) Tan Tock Seng Hospital, Singapore Case scenario
More informationClinical Policy: Ranolazine (Ranexa) Reference Number: CP.PMN.34 Effective Date: Last Review Date: 02.19
Clinical Policy: (Ranexa) Reference Number: CP.PMN.34 Effective Date: 08.01.09 Last Review Date: 02.19 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important
More informationMeasure #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients)
Measure #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) 2013 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage
More informationSURGICAL CARE IMPROVEMENT PROJECT QUALITY MEASURES
SURGICAL CARE IMPROVEMENT PROJECT QUALITY MEASURES Hospitals can reduce the risk of infection after surgery by making sure they provide the standard of care that is known to get the best results for most
More informationStroke Quality Measures. Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed: May, 2012 Most recently updated: December 2012
1 Stroke Quality Measures Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed: May, 2012 Most recently updated: December 2012 2 Application of the Stroke Measure Set The stroke
More informationTHROMBOPROPHYLAXIS: NON-ORTHOPEDIC SURGERY
THROMBOPROPHYLAXIS: NON-ORTHOPEDIC SURGERY OBJECTIVE: To outline a practical approach for the prevention of venous thromboembolism (VTE) in patients undergoing non-orthopedic surgery. BACKGROUND: VTE is
More informationVenous Thromboembolism Prophylaxis
Approved by: Venous Thromboembolism Prophylaxis Vice President and Chief Medical Officer; and Vice President and Chief Operating Officer Corporate Policy & Procedures Manual Number: Date Approved January
More informationGetting Started Kit VENOUS THROMBOEMBOLISM PREVENTION. Section 2: Evidence-Based Appropriate VTE Prophylaxis
Reducing Harm Improving Healthcare Protecting Canadians VENOUS THROMBOEMBOLISM PREVENTION Getting Started Kit Section 2: Evidence-Based Appropriate VTE Prophylaxis January 2017 www.patientsafetyinstitute.ca
More informationPerioperative VTE Prophylaxis
Perioperative VTE Prophylaxis Gregory J. Misky, M.D. Assistant Professor of Medicine University Of Colorado Denver You recommend the following 72 y.o. man admitted for an elective R hip repair. Patient
More informationCardiac Medications At A Glance
Cardiac Medications At A Glance 1) Anticoagulants (Also known as Blood Thinners.) Dalteparin (Fragmin), Danaparoid (Orgaran) Enoxaparin (Lovenox) Heparin (various) Tinzaparin (Innohep) Warfarin (Coumadin)
More information2012 Core Measures. Acute Myocardial Infarction (AMI)
2012 Core Measures Acute Myocardial Infarction (AMI) Aspirin at Arrival Aspirin Prescribed at Discharge Angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) for left ventricular
More informationComparison of Oral Beta-Blockers
This Clinical Resource gives subscribers additional insight related to the Recommendations published in March 2017 ~ Resource #330356 Comparison of Oral Beta-Blockers Noncardioselective s (beta-1 and beta-2
More informationINDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY
INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY N.E. Pearce INTRODUCTION Preventable death Cause of morbidity and mortality Risk factors Pulmonary embolism
More informationPreventing and Managing High Blood Pressure
MINTO PREVENTION & REHABILITATION CENTRE CENTRE DE PREVENTION ET DE READAPTATION MINTO Preventing and Managing High Blood Pressure About This Kit Fortunately, high blood pressure is easily detected and
More informationEarly Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Marilyn Szekendi, PhD, RN
Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement Marilyn Szekendi, PhD, RN ANA 7 th Annual Nursing Quality Conference, February 2013 Research Team Banafsheh Sadeghi,
More informationTo be ordered if results are not on the chart or have not already been ordered.
r*po1004*r PO1004 Page 1 of 3 DATE HOUR PRE OP STANDING ORDERS To be ordered if results are not on the chart or have not already been ordered. Do not duplicate orders from other sources. 1. No narcotics
More informationVenous Thromboembolism Prophylaxis - Why Should We Care? Harry Gibbs FRACP FCSANZ Vascular Physician The Alfred Hospital
Venous Thromboembolism Prophylaxis - Why Should We Care? Harry Gibbs FRACP FCSANZ Vascular Physician The Alfred Hospital VTE is common and dangerous 5 VTE is Common VTE Incidence: 1.5 / 1000 per year
More informationUCLA Health System Apr - Jun 2013 (Q2)
Denom Observed VBP Standard VBP Benchmark Denom Observed VBP Standard VBP Benchmark N Percent x/n N Percent x/n Value Based Purchasing-Clinical Process of Care Measures (%) SCIP-Inf-9 Urinary catheter
More informationSouth Carolina Department of Health and Human Services Post Office Box 8206 Columbia, South Carolina
South Carolina Department of Health and Human Services Post Office Box 8206 Columbia, South Carolina 29202-8206 Pharmacy and Therapeutics (P&T) Committee Meeting MINUTES 1. Call To Order A meeting of the
More informationThe following report contains a description of the request, request specifications, and results from the modular program run(s).
Disclaimer The following report(s) provides findings from an FDA initiated query using Sentinel. While Sentinel queries may be undertaken to assess potential medical product safety risks, they may also
More informationVenous Thromboembolism Prophylaxis: Checked!
Venous Thromboembolism Prophylaxis: Checked! William Geerts, MD, FRCPC Director, Thromboembolism Program, Sunnybrook HSC Professor of Medicine, University of Toronto National Lead, VTE Prevention, Safer
More informationStudy Exposures, Outcomes:
GSK Medicine: Coreg IR, Coreg CR, and InnoPran Study No.: WWE111944/WEUSRTP3149 Title: A nested case-control study of the association between Coreg IR and Coreg CR and hypersensitivity reactions: anaphylactic
More information12.5mg, 25mg, 50mg. 25mg, 50mg. 2.5mg, 5mg, 10mg. 5mg, 10mg, 20mg, 100mg. 25mg. -- $2.81 Acetazolamide (IR, 125mg, 250mg, 500mg (ER)
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Blood Pressure P&T DATE: 5/9/2017 THERAPEUTIC CLASS: Cardiovascular Disorders REVIEW HISTORY: 9/15, 2/13, 2/08, 5/07 LOB
More informationHEDIS. Quick Reference Guide. For more information, visit
HEDIS Quick Reference Guide For more information, visit www.ncqa.org HEDIS Quick Reference Guide Updated to reflect NCQA HEDIS 2018 Technical Specifications Michigan Complete Health strives to provide
More informationSurgical Care, Pneumonia, Immunizations and Emergency Department Core Measures
Surgical Care, Pneumonia, Immunizations and Emergency Department Core Measures Audrey Paulman, MD, MMM Principal Clinical Coordinator & Jackie Trojan, RN, BSN Quality Improvement Advisor This material
More informationHEDIS Quick Reference Guide Updated to reflect NCQA HEDIS 2016 Technical Specifications
HEDIS Quick Reference Guide Updated to reflect NCQA HEDIS 2016 Technical Specifications Fidelis SecureCare strives to provide quality healthcare to our membership as measured through HEDIS quality metrics.
More informationThis Core Measure Report shows performance to date. CAVEAT: Data collection is still in progress for the current and immediate past quarter!
This Core Measure Report shows performance to date. CAVEAT: Data collection is still in progress for the current and immediate past quarter! AMI-1 -- Aspirin at Arrival 9 8 7 6 5 4 3 2 1 AMI-2 -- Aspirin
More informationSUNY Downstate Medical Center/University Hospital Oct - Dec 2013 (Q4)
Value Based Purchasing-Clinical Process of Care Measures Denom Observed VBP VBP Benchmark Standard Denom Observed VBP VBP Benchmark Standard N Percent x/n N Percent x/n SCIP-Inf-9 Urinary catheter removed
More informationSCORES FOR 4 TH QUARTER, RD QUARTER, 2014
SCORES FOR 4 TH QUARTER, 2013 3 RD QUARTER, 2014 PATIENT SATISFACTION SCORES (HCAHPS): 4 STARS OUT OF 5 (ONLY 4 AREA ACUTE CARE HOSPITALS RECEIVED A 4-STAR RATING. NONE ACHIEVED 5-STARS). STRUCTURAL MEASURES:
More informationDVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center
DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients David Liff MD Oklahoma Heart Institute Vascular Center Overview Pathophysiology of DVT Epidemiology and risk factors for DVT in the
More informationUW MEDICINE PATIENT EDUCATION. Get Active Your weight-loss success depends on it! Why is exercise so important? Your body needs exercise both
UW MEDICINE PATIENT EDUCATION Get Active Your weight-loss success depends on it! This chapter explains the exercise you must do to qualify for bariatric surgery. It outlines an exercise plan and includes
More informationTarkten A Pharr, MD, FACS 04/26/2018. VTE Prevention Strategies: Is a One Size Fits all Approach Correct?
Tarkten A Pharr, MD, FACS 04/26/2018 VTE Prevention Strategies: Is a One Size Fits all Approach No disclosures... Why do we care? Where is this is the realm of public health concerns? Incidence/Prevalence
More informationLiving with Congestive Heart Failure: A Guide to a Healthy Heart
Living with Congestive Heart Failure: A Guide to a Healthy Heart Things to Know, Before You Go Dear Patient/Caregiver These are the things you NEED TO KNOW, BEFORE YOU GO. It is very important that you
More informationRequest for Administration of Immunotherapy At an Outside Medical Facility
Amy L. Darter, M.D. FACAAI, FAAAAI 1810 East Memorial Road, Oklahoma City, OK 73131 (P) 405.607.4333 (F) 405.607.4404 www.okallergy.com Request for Administration of Immunotherapy At an Outside Medical
More informationVenous Thromboembolism National Hospital Inpatient Quality Measures
Venous Thromboembolism National Hospital Inpatient Quality Measures Presentation Overview Review venous thromboembolism as a new mandatory measure set Outline measures with exclusions and documentation
More informationHEDIS. Quick Reference Guide. For more information, visit
HEDIS Quick Reference Guide For more information, visit www.ncqa.org HEDIS Quick Reference Guide Updated to reflect NCQA HEDIS 2017 Technical Specifications Michigan Complete Health Medicare-Medicaid Plan
More informationPhysician's Core Measure Pocket Guide AMI
Physician's Core Measure Pocket Guide Core Measure Hotline: Ext. 4448 http://centegramedsource.com Indicator: AMI AMI VER. 9/2018 MUST document WHY no ASA unless there is documentation of contraindication
More informationVTE Management in Surgical Patients: Optimizing Prophylaxis Strategies
VTE Management in Surgical Patients: Optimizing Prophylaxis Strategies VTE in Surgical Patients: Recognizing the Patients at Risk Pathogenesis of thrombosis: Virchow s triad and VTE Risk Hypercoagulability
More informationCMS National Patient Safety Initiative for Surgical Care
CMS National Patient Safety Initiative for Surgical Care Ongoing Opportunities for Improvement Dale W. Bratzler, DO, MPH President and CEO Oklahoma Foundation for Medical Quality An update where are we
More informationTexas Sinus Center San Antonio La Cantera Pkwy, #20210 San Antonio, TX (210)
San Antonio 15900 La Cantera Pkwy, #20210 San Antonio, TX 78256 (210) 807-7254 Boerne 34910 IH-10 West, Bldg. 3 Boerne, TX 78006 (830) 816-3838 ALLERGY TESTING INFORMATION 1. On the day of testing please
More informationPERSISTENCE OF BETA BLOCKER TREATMENT AFTER A HEART ATTACK
PERSISTENCE OF BETA BLOCKER TREATMENT AFTER A HEART ATTACK APPLICATIONS OBJECTIVE Purpose of Measure: ELIGIBLE POPULATION Which members are included? HEDIS (Administrative) NCQA Accreditation (Medicare
More informationREVISED RESPIRATORY MEDICATION USE QUESTIONNAIRE
REVISED RESPIRATORY MEDICATION USE QUESTIONNAIRE ID NUMBER: 0a) Date of Collection / / 0b) Staff Code Instructions: This form should be completed during the participant s clinic visit. 1) Are you regularly
More informatione-module Centers for Medicaid and Medicare (CMS) Core Measures
Centers for Medicaid and Medicare (CMS) Core Measures 1 Purpose The purpose of this e-learning module is to provide education for health care providers on Core Measures. This module is not all inclusive,
More information100 mg atenolol equivalent to metoprolol
100 mg atenolol equivalent to metoprolol Metoprolol is a selective beta-blocker at dosages usually prescribed to lower blood. For High Blood Pressure For 7 years I have been on 50 mg. of atenolol for.
More informationPrevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales
Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales Merimbula, 6 th November 2010 University of Sydney Department of Surgery Westmead Hospital
More informationTexas Prior Authorization Program Clinical Edit Criteria
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization
More informationWhat evidence exists that describes the efficacy of mechanical prophylaxis for venous thromboembolism (VTE) in adult surgical patients?
July 2015 Rapid Review Evidence Summary McGill University Health Centre: Division of Nursing Research and MUHC Libraries What evidence exists that describes the efficacy of mechanical prophylaxis for venous
More informationGENERAL SURGICAL ADULT POST-OPERATIVE ORDERS 1 of 4
down ADULT POST-OPERATIVE 1 of 4 9 Actual 9 Estimated Patient ID Area Weight kg 9 Actual 9 Estimated Height cm ALLERGIES: REFER TO ALLERGY PROFILE/ POWERCHART Admit to: Post Anesthesia Care Unit (PACU),
More informationQuality Committee Core Measures Report AMI. Acute Myocardial Infarction
AMI 2011 Acute Myocardial Infarction ASPIRIN AT ARRIVAL: A higher number is better. This measure shows the percentage of heart attack patients who receive aspirin within 24 hrs of arrival at hospital.
More informationADULT TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) TELEMETRY BED TRANSFER ORDERS 1 of 4
TELEMETRY BED TRANSFER 1 of 4 9 Actual 9 Estimated Patient ID Area Weight kg 9 Actual 9 Estimated Height cm ALLERGIES: REFER TO ALLERGY PROFILE/ POWERCHART Transfer to: 10 South Attending Physician: Diagnosis:
More informationPostsurgical Home Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis
Clinical Position Statement Postsurgical Home Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Effective: October 2017 Next Review: September 2018 CLINICAL POSITION STATEMENT Postsurgical
More informationGuideline Quick View: Venous Thromboembolism
Guideline Quick View: Venous Thromboembolism The AORN Guideline Quick View is a key component of Guideline Essentials, a suite of online implementation tools designed to help the perioperative team translate
More informationThe Royal College of Emergency Medicine. VTE Risk in Lower Limb Immobilisation in Plaster Cast 2015/2016
The Royal College of Emergency Medicine Clinical Audits VTE Risk in Lower Limb Immobilisation in Plaster Cast Introduction 2015/2016 EXCELLENCE IN EMERGENCY MEDICINE A significant number of patients attend
More informationDisclosures. Venous Thromboembolism Prophylaxis: What every orthopaedic surgeon needs to know. Published Guidelines
Venous Thromboembolism Prophylaxis: What every orthopaedic surgeon needs to know Paul F. Lachiewicz, MD Chapel Hill Orthopedic Surgery & Sports Medicine Consulting Professor Duke Orthopaedic Surgery Disclosures
More informationOrthopedic Admission Hip Fracture Version 2 1/25/2017
Patient Name: Initial each page and Sign/Date/Time last page Diagnosis: Allergies with reaction type: Orthopedic Admission Hip Fracture Version 2 1/25/2017 Patient Placement Patient Status If the physician
More informationCorporate Medical Policy
Corporate Medical Policy Postsurgical Home Use of Limb Compression Devices for Venous File Name: Origination: Last CAP Review: Next CAP Review: Last Review: postsurgical_home_use_of_limb_ compression_devices_for_vte_prophylaxis
More informationPET Cardiac Sarcoid Testing with Rest/Stress Test
PET Cardiac Sarcoid Testing with Rest/Stress Test What is a PET Cardiac Sarcoid Test with Rest/Stress Test? PET Cardiac Sarcoid Test with Rest/Stress test takes a picture of your heart. This is done to
More informationNational Quality Improvement Project 2018/2019 VTE Risk in Lower Limb Immobilisation Information Pack
National Quality Improvement Project 2018/2019 VTE Risk in Lower Limb Immobilisation Information Pack Introduction... 2 Methodology... 3 Flow of data searches to identify audit cases... 3 Data entry information...
More informationThese are guidelines only and can be deviated from if it is thought to be in the patient s best interest.
Clinical Guideline Venothromboembolism prophylaxis: Trauma and Orthopaedics Venous thromboembolism (VTE) is a recognised complication associated with inactivity and surgical procedures. Therefore, all
More informationPatterns of Failure of a Standardized Perioperative Venous Thromboembolism Prophylaxis Protocol
Patterns of Failure of a Standardized Perioperative Venous Thromboembolism Prophylaxis Protocol Ryan Macht MD, Michael Cassidy MD, Pamela Rosenkranz RN BSN MEd, Joseph Caprini MD FACS, David McAneny MD
More informationData Dictionary ; Revised ; ; , 07.07,09.07,04.08 Items in bold italics are recent changes/additions
Data Dictionary 05.31.06; Revised 06.12.06; 07.24.06; 12.30.06, 07.07,09.07,04.08 Items in bold italics are recent changes/additions Number Data element Definition Usual Source in Medical Demographic information
More informationClinical Practice Guideline for Patients Requiring Total Hip Replacement
Clinical Practice Guideline for Patients Requiring Total Hip Replacement Inclusions Patients undergoing elective total hip replacement Exclusions Patients with active local or systemic infection or medical
More informationCARD THORACOTOMY PRE-OP PLAN
CARD THORACOTOMY PRE-OP PLAN PHYSICIAN S Diagnosis Weight Allergies Patient Care Perform Oral Care Perform night before surgery. Brush teeth with toothpaste, then swish and spit 15 ml chlorhexidine mouth
More informationMedical History. Patient s Last Name: First: Middle Initial: DOB
Medical History Patient s Last Name: First: Middle Initial: DOB PAST MEDICAL HISTORY: (PLEASE CIRCLE ALL THAT APPLY) Anemia Breast Cancer Heartburn / Acid Reflux Thyroid Problems Seizures Anxiety Colon
More informationOur Commitment to Quality and Patient Safety Core Measures
Calvert Memorial Hospital is committed to our community, with a focus on patient-centered care. High quality and safe patient care is not our goal, it is our priority. That means delivering the best possible
More informationVenothromboembolism prophylaxis: Trauma and Orthopaedics Clinical guideline, V2
Clinical Guideline Venothromboembolism prophylaxis: Trauma and Orthopaedics 11/11/11 TEMPORARY GUIDANCE There is no prophylactic tinzaparin available in the Trust currently. Please substitute enoxaparin
More informationThe NOF & NBHA Quality Improvement Registry
In collaboration with CECity The NOF & NBHA Quality Improvement Registry This registry is approved by CMS as a Qualified Clinical Data Registry (QCDR) for Eligible Professionals and GPRO Practices for
More informationIntegrating Sentinel into Routine Regulatory Drug Review: A Snapshot of the First Year. Risk of seizures associated with Ranolazine (Ranexa)
Integrating Sentinel into Routine Regulatory Drug Review: A Snapshot of the First Year Risk of seizures associated with Ranolazine (Ranexa) Efe Eworuke, PhD Division of Epidemiology Office of Pharmacovigilance
More informationMeasurement and Improvement of Quality of Cardiovascular Care DR : DEHESTANI
Measurement and Improvement of Quality of Cardiovascular Care DR : DEHESTANI Hospitals For hospitals in the United States, measures of cardiovascular care mandated by the Joint Commission have recently
More informationCodes for a Medicare claims-based model to predict LVEF class- User Guide
Description and citation: This guide accompanies our manuscript [Desai RJ, Lin KJ, Patorno E, et al. Development and Preliminary Validation of a Medicare Claims Based Model to Predict Left Ventricular
More informationASH Draft Recommendations for VTE Prevention in Surgical Hospitalized Patients DRAFT
ASH Draft Recommendations for VTE Prevention in Surgical Hospitalized Patients INTRODUCTION American Society of Hematology (ASH) guidelines are based on a systematic review of available evidence. Through
More informationGlobal Immunization Measures. Developed by: Kathy Wonderly RN, MSEd, CPHQ Consultant Created: September, 2011 Most recent update: December, 2018
Global Immunization Measures Developed by: Kathy Wonderly RN, MSEd, CPHQ Consultant Created: September, 2011 Most recent update: December, 2018 Global Immunization Measure Set Since these measures are
More information*Corresponding Author:
Audit of venous thromboembolism prophylaxis administered to general surgical patients undergoing elective and emergency operations at National Hospital, Sri Lanka *Migara Seneviratne 1, Asanka Hemachandra
More informationLIMB COMPRESSION DEVICES FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS
PROPHYLAXIS Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are dependent
More informationWhat You Should Know
1 New 2018 ASH Clinical Practice Guidelines on Venous Thromboembolism: What You Should Know New 2018 ASH Clinical Practice Guidelines on Venous Thromboembolism: What You Should Know The American Society
More informationALLERGY QUESTIONNAIRE. Patient Name
ALLERGY QUESTIONNAIRE Patient Name_ DOB: _ What problem brings you to this appointment? When did symptoms begin? Please check all symptoms that apply. NOSE Runny Nose Nasal Congestion Itchy Nose Postnasal
More informationVenous thromboembolism: reducing the risk
Issue date: January 2010 Venous thromboembolism: reducing the risk Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital This guideline
More informationADULT CARDIAC SURGERY TELEMETRY BED TRANSFER ORDERS 1 of 4
ADULT CARDIAC SURGERY TELEMETRY BED TRANSFER 1 of 4 9 Actual 9 Estimated Attending Surgeon: Medical Record Number Weight kg 9 Actual 9 Estimated Height cm ALLERGIES: REFER TO ALLERGY PROFILE/ POWERCHART
More informationPage: 1 of 13. Post-Surgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis
Last Review Status/Date: March 2014 Page: 1 of 13 Compression Devices for Venous Description Patients undergoing major orthopedic surgery are at increased risk for venous thromboembolism (VTE). Patients
More informationVENOUS THROMBOEMBOLISM (VTE) PREVENTION MEDICAL PROVIDER EDUCATION JUNE 2017
VENOUS THROMBOEMBOLISM (VTE) PREVENTION MEDICAL PROVIDER EDUCATION JUNE 2017 VTE IS THE 2 ND MOST COMMON HOSPITAL ACQUIRED CONDITION RISK FACTORS DECREASED ACTIVITY = VTE RISK (NURSES MEASURE WITH BRADEN
More information